Wednesday, November 11, 2026
ExploreSearch
Via News
Via News Knowledge File

Oracle Corporation

organization80% conf.·synced Nov 11, 2026

Technology company that adopted Custom AI Companion for global workforce AI assistants

60
sourced metrics
779
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week High
248.15USD
Nov 10, 2026reference only
Stock Price
117.98USD
Nov 10, 2026reference only
Price 52 Week Low
114.99USD
Nov 10, 2026reference only
Market Cap
339837968580USD
Nov 10, 2026reference only
Stock Return Ytd
-39.7%
Nov 10, 2026reference only
Shares Outstanding
2880471000.0shares
Jun 12, 2026reference only
Cash
31289000000.0USD
May 31, 2026reference only
Total Assets
261759000000.0USD
May 31, 2026reference only
Revenue
67357000000.0USD
May 31, 2026reference only
Operating Cash Flow
31977000000.0USD
May 31, 2026reference only
Capex
55663000000.0USD
May 31, 2026reference only
Stockholders Equity
42508000000.0USD
May 31, 2026reference only
Net Income
17087000000.0USD
May 31, 2026reference only
Eps
5.83USD_per_share
May 31, 2026reference only
Rd Expense
10272000000.0USD
May 31, 2026reference only
Operating Income
20606000000.0USD
May 31, 2026reference only

Stated objectives

Oracle plans to raise up to $50 billion for cloud buildout

source
target: 50 billion USD by 2026-12-31 00:00:00stated

Raise capex forecast to around $50 billion for AI data centers

source
target: 50 billion USD stated

Oracle Cloud Infrastructure revenue growth

source
target: 4.1 billion USD (68% climb) stated

Build AI data centers

source
target: 50 billion USD capex stated

Oracle launched AI-driven supply chain tools to predict disruptions and optimize inventory levels

source
by 2025-01-01 00:00:00stated

Oracle targets continued cloud acceleration and data center capacity expansion in FY2026

source
stated

Capital spending on AI infrastructure

source
target: 500+ billion USD by 2026-01-01 00:00:00stated

Accelerate revenue and profit growth through AI infrastructure capital expenditure

source
stated

Spend on CapEx right before it starts generating revenue

source
stated

Increased guidance for 2027 revenues by $4 billion

source
target: 4 billion USD increase by 2027-01-01 00:00:00stated

Relationship graph · 779 connections

Competes with
136
Developed by
107
Covered by
97
Customer of
75
Supplies to
68
Employs
38
located in
27
headquartered in
23

Via News coverage

CFOs Plan 50%+ AI Budget Jumps as BlackLine, Oracle, and OneStream Race to Build Agentic Finance Platforms
May 20, 2026
Nearly 25% of CFOs Plan to Boost AI Spend by 50%-Plus as BlackLine, Oracle, and Startups Converge on Finance Automation
May 18, 2026
Pershing Square Builds Microsoft Stake as Oracle Borrows to Fund Data Centers
May 17, 2026
Numero AI, BlackLine, and Oracle Signal Industry Shift to Autonomous CFO Operations
May 17, 2026
BlackLine and Oracle Race to Deploy AI Agents in Enterprise Finance as CFO Budgets Climb
April 27, 2026
BlackLine, Oracle, and OneStream Race to Deploy Autonomous AI Agents Across Enterprise Finance
April 26, 2026
Oracle Health Gains CMS Aligned Network Status as Federal Initiatives Push Healthcare AI Integration
April 22, 2026
BlackLine and Oracle Deploy Autonomous AI Agents to Execute Enterprise Financial Tasks
April 21, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com